Barely Significant
← all phrases

“borderline significant”

11,410 sentences · 11,410 papers · 14,072 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

borderline significantp=0.0591.2× alphagold
Consistent with these observations, HPV-positive OPSCC showed non-aggressive tumour invasive front (p=0.001), little desmoplastic stromal reaction (p=0.059, borderline significant), and rich inflammatory host reaction (p=0.013) than HPV-negative OPSCC.
borderline significantp = 0.05951.2× alphagold
After additional adjustments for diabetes, hypertension, and dyslipidemia (Model 5), as well as chronic kidney disease (Model 6), the associations were slightly attenuated but remained significant for the PU-persistent group (aHR: 1.27; 95% CI, 1.13–1.42; p = 0.0008), became borderline significant for the PU-developed group (aHR: 1.07; 95% CI, 1.00–1.16; p = 0.0595), and were not significant for the PU-recovered group (aHR: 1.06; 95% CI, 0.98–1.14; p = 0.1543) (p for trend < 0.0001) (Model 6 of Table 2 ).
borderline significantp=0.05971.2× alphagold
Median PFAS serum levels did not differ significantly between those who did and did not take the survey for PFNA (p=0.1526), PFOA (p=0.4913), and PFHxS (p=0.6973), but for PFOS the median serum levels were lower among those who took the health survey and this difference was borderline significant (7.25 μg/L sd 4.50, and 8.37 μg/L sd 5.57, respectively p=0.0597).
borderline significantP = 0.061.2× alphagold
Findings from the UPenn cohort supported the prognostic value of CSF AcTau174 in FTLD-TDP; higher baseline AcTau174 was associated with a faster rate of cognitive decline as measured by MMSE, although this association was borderline significant ( β = −1.63; 95% CI = −3.25, −0.05, P = 0.06; Fig. 3c and Extended Data Table 3 ).
borderline significantP = 0.061.2× alphagold
The repeated measures of ANOVA revealed the saxagliptin plus vitamin D group was significantly different compared with the conventional therapy group ( P = 0.001), and the full least-squares models indicated a significant difference of mean change of 2-h C-peptide AUC between the saxagliptin plus vitamin D group and the conventional therapy group at 12 months, 18 months and 24 months ( P = 0.023, 0.038 and 0.013, respectively), and a borderline significant difference at 6 months ( P = 0.06).